Kelson Michael Figaro

Kelson Figaro practices at I C Care Corporation in Upper Marlboro, Maryland.

Kelson Figaro's NPI, 1831128750, was assigned on July 2, 2006. Kelson Figaro holds Maryland license D0052865.

Kelson Figaro's primary practice is I C Care Corporation, at 1100 Mercantile Ln, Upper Marlboro, MD 20774. The practice phone is (301) 773-9700.

Kelson Figaro's primary practice is I C Care Corporation in Upper Marlboro, Maryland. Kelson Figaro is also affiliated with Winchester Medical Center. The medical group on file is MedStar Medical Group. Dmand AI also links Kelson Figaro to 1 more hospital, 11 medical groups, 7 skilled nursing facilities, 3 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kelson Figaro practices, 14 sites in all. Vendor and product names are available with a free account.

Internal medicine is Kelson Figaro's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kelson Figaro is licensed in Maryland.

CMS data shows 1,991 Medicare services from Kelson Figaro across 12 procedure codes in 2024, for 564 Medicare patients. Medicare paid $193,296 for them.

CMS counts 564 Medicare patients who saw Kelson Figaro in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kelson Figaro's median patient age at 77, with 57% women.

In 2024, Kelson Figaro wrote 8,208 Medicare Part D claims for 391 patients. 84% of them were for generic drugs. CMS names the drug for 7,437 of them, across 148 drugs with 11 or more claims each, at $612,329 in total drug cost. In 2023, CMS named 5,430 claims across 135 drugs.

Kelson Figaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 65 general payments to Kelson Figaro from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $281.